• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳洛酮诱发吗啡戒断的动机和躯体成分的神经关联

Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.

作者信息

Frenois François, Cador Martine, Caillé Stéphanie, Stinus Luis, Le Moine Catherine

机构信息

Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5541 Interactions Neuronales et Comportements, BP28, Université Victor Segalen, Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux cedex, France.

出版信息

Eur J Neurosci. 2002 Oct;16(7):1377-89. doi: 10.1046/j.1460-9568.2002.02187.x.

DOI:10.1046/j.1460-9568.2002.02187.x
PMID:12405997
Abstract

In morphine-dependent rats, low naloxone doses have been shown to induce conditioned place aversion, which reflects the negative motivational component of opiate withdrawal. In contrast, higher naloxone doses are able to induce a 'full' withdrawal syndrome, including overt somatic signs. The c-fos gene is commonly used as a marker of neuronal reactivity to map the neural substrates that are recruited by various stimuli. Using in situ hybridization, we have analysed in the brain of morphine-dependent rats the effects of acute withdrawal syndrome precipitated by increasing naloxone doses on c-fos mRNA expression. Morphine dependence was induced by subcutaneous implantation of slow-release morphine pellets for 6 days and withdrawal was precipitated by increasing naloxone doses inducing the motivational (7.5 and 15 micro g/kg) and somatic (30 and 120 micro g/kg) components of withdrawal. Our mapping study revealed a dissociation between a set of brain structures (extended amygdala, lateral septal nucleus, basolateral amygdala and field CA1 of the hippocampus) which exhibited c-fos mRNA dose-dependent variations from the lowest naloxone doses, and many other structures (dopaminergic and noradrenergic nuclei, motor striatal areas, hypothalamic nuclei and periaqueductal grey) which were less sensitive and recruited only by the higher doses. In addition, we found opposite dose-dependent variations of c-fos gene expression within the central (increase) and the basolateral (decrease) amygdala after acute morphine withdrawal. Altogether, these results emphasize that limbic structures of the extended amygdala along with the lateral septal nucleus, the basolateral amygdala and CA1 could specifically mediate the negative motivational component of opiate withdrawal.

摘要

在吗啡依赖大鼠中,低剂量纳洛酮已被证明可诱发条件性位置厌恶,这反映了阿片类药物戒断的负性动机成分。相比之下,较高剂量的纳洛酮能够诱发“完全”戒断综合征,包括明显的躯体症状。c-fos基因通常用作神经元反应性的标志物,以绘制由各种刺激募集的神经底物。通过原位杂交,我们在吗啡依赖大鼠的脑中分析了增加纳洛酮剂量引发的急性戒断综合征对c-fos mRNA表达的影响。通过皮下植入缓释吗啡丸6天诱导吗啡依赖,通过增加纳洛酮剂量引发戒断,这些剂量可诱发戒断的动机性(7.5和15微克/千克)和躯体性(30和120微克/千克)成分。我们的图谱研究揭示了一组脑结构(扩展杏仁核、外侧隔核、基底外侧杏仁核和海马的CA1区)之间的分离,这些结构从最低纳洛酮剂量开始就表现出c-fos mRNA的剂量依赖性变化,而许多其他结构(多巴胺能和去甲肾上腺素能核、运动纹状体区域、下丘脑核和导水管周围灰质)敏感性较低,仅在较高剂量时才被募集。此外,我们发现急性吗啡戒断后,中央杏仁核(增加)和基底外侧杏仁核(减少)内c-fos基因表达存在相反的剂量依赖性变化。总之,这些结果强调,扩展杏仁核的边缘结构以及外侧隔核、基底外侧杏仁核和CA1区可能特异性介导阿片类药物戒断的负性动机成分。

相似文献

1
Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.纳洛酮诱发吗啡戒断的动机和躯体成分的神经关联
Eur J Neurosci. 2002 Oct;16(7):1377-89. doi: 10.1046/j.1460-9568.2002.02187.x.
2
Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.杏仁核中央核激活终纹床核参与大鼠吗啡戒断的负性情感成分。
Neuroscience. 2005;134(1):9-19. doi: 10.1016/j.neuroscience.2005.03.029.
3
Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.大鼠中央杏仁核中c-Fos的表达与急性吗啡依赖戒断诱导的条件性位置厌恶的获得有关,但与表达无关。
Behav Brain Res. 2005 Jun 3;161(1):107-12. doi: 10.1016/j.bbr.2005.01.012. Epub 2005 Feb 17.
4
Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion.阿片类药物戒断诱导的大鼠终纹床核-杏仁核扩展亚区Fos免疫反应性与条件性位置厌恶的发展平行。
Neuropsychopharmacology. 2001 Feb;24(2):152-60. doi: 10.1016/S0893-133X(00)00186-X.
5
c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawal.纳洛酮诱发戒断后吗啡依赖大鼠中枢扩展杏仁核中的c-Fos和肽免疫反应性
Eur J Neurosci. 2003 Sep;18(5):1295-305. doi: 10.1046/j.1460-9568.2003.02837.x.
6
The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure.谷氨酸释放抑制剂利鲁唑可减轻单次吗啡暴露大鼠中由纳洛酮诱导的条件性位置厌恶的形成。
Brain Res. 2006 Jan 19;1069(1):120-6. doi: 10.1016/j.brainres.2005.11.058. Epub 2005 Dec 20.
7
Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.杏仁核中央核内谷氨酸受体参与大鼠纳洛酮诱发的吗啡戒断所致条件性位置厌恶。
Jpn J Pharmacol. 2002 Apr;88(4):399-406. doi: 10.1254/jjp.88.399.
8
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.丁丙诺啡和一种促肾上腺皮质激素释放因子1拮抗剂可阻断大鼠中阿片类药物戒断诱导的条件性位置厌恶的形成。
Neuropsychopharmacology. 2005 Jan;30(1):90-8. doi: 10.1038/sj.npp.1300487.
9
[Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].[杏仁核在单剂量吗啡处理大鼠中对纳洛酮诱导的位置厌恶的影响]
Yakugaku Zasshi. 2008 Mar;128(3):395-403. doi: 10.1248/yakushi.128.395.
10
Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved.吗啡依赖和诱发戒断期间大脑中c-fos基因表达的图谱绘制以及所涉及纹状体神经元的表型鉴定。
Eur J Neurosci. 2000 Dec;12(12):4475-86. doi: 10.1046/j.0953-816x.2000.01334.x.

引用本文的文献

1
The influence of morphine treatment on the opioid propeptide gene expression in the forebrain of two inbred mouse strains with different sensitivity to opioids.吗啡处理对两种对阿片类药物敏感性不同的近交系小鼠前脑阿片前体肽基因表达的影响。
Pharmacol Rep. 2025 Aug 14. doi: 10.1007/s43440-025-00769-8.
2
Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice.雄性小鼠急性和慢性吗啡戒断引起的负性情绪模型。
Sci Rep. 2024 Apr 29;14(1):9767. doi: 10.1038/s41598-024-60759-3.
3
Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence.
阿片类物质戒断及长期阿片类物质戒断期时,终纹床核扩展杏仁核的神经可塑性。
Front Pharmacol. 2023 Nov 16;14:1253736. doi: 10.3389/fphar.2023.1253736. eCollection 2023.
4
Improving Translational Research Outcomes for Opioid Use Disorder Treatments.改善阿片类物质使用障碍治疗的转化研究成果。
Curr Addict Rep. 2021 Mar;8(1):109-121. doi: 10.1007/s40429-020-00353-5. Epub 2021 Jan 12.
5
Opioid withdrawal: role in addiction and neural mechanisms.阿片类药物戒断:成瘾中的作用和神经机制。
Psychopharmacology (Berl). 2023 Jul;240(7):1417-1433. doi: 10.1007/s00213-023-06370-2. Epub 2023 May 10.
6
Advances in the characterization of negative affect caused by acute and protracted opioid withdrawal using animal models.使用动物模型研究急性和慢性阿片类戒断引起的负性情绪的特征进展。
Neuropharmacology. 2023 Jul 1;232:109524. doi: 10.1016/j.neuropharm.2023.109524. Epub 2023 Mar 30.
7
Opioid Withdrawal Abruptly Disrupts Amygdala Circuit Function by Reducing Peptide Actions.阿片类戒断通过减少肽作用突然破坏杏仁核回路功能。
J Neurosci. 2023 Mar 8;43(10):1668-1681. doi: 10.1523/JNEUROSCI.1317-22.2022. Epub 2023 Feb 13.
8
NEURONAL CORRELATES OF HYPERALGESIA AND SOMATIC SIGNS OF HEROIN WITHDRAWAL IN MALE AND FEMALE MICE.雄性和雌性小鼠中痛觉过敏的神经元关联及海洛因戒断的躯体症状
eNeuro. 2022 Jun 21;9(4). doi: 10.1523/ENEURO.0106-22.2022.
9
Molecular Mechanisms Underlying the Retrieval and Extinction of Morphine Withdrawal-Associated Memories in the Basolateral Amygdala and Dentate Gyrus.基底外侧杏仁核和齿状回中与吗啡戒断相关记忆的提取与消退的分子机制
Biomedicines. 2022 Mar 2;10(3):588. doi: 10.3390/biomedicines10030588.
10
The role of hippocampus in memory reactivation: an implication for a therapeutic target against opioid use disorder.海马体在记忆再激活中的作用:对阿片类药物使用障碍治疗靶点的启示。
Curr Addict Rep. 2022;9(2):67-79. doi: 10.1007/s40429-022-00407-w. Epub 2022 Feb 19.